Differential gene expression and gene-set enrichment analysis in Caco-2 monolayers during a 30-day timeline with Dexamethasone exposure

References

• Soderholm JD, Perdue MH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol. 2001;280(1):G7–G13. doi:10.1152/ajpgi.2001.280.1.G7.
   PubMed Web of Science ®Google Scholar
• Buttgereit F, Burmester G-R, Lipworth BJ. Optimised glucocorticoid therapy: the sharpening of an old spear. The Lancet. 2005;365(9461):801–803. doi:10.1016/S0140-6736(05)17989-6.
   PubMed Web of Science ®Google Scholar
• Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17(4):233–247. doi:10.1038/nri.2017.1.
   PubMed Web of Science ®Google Scholar
• Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2–13. doi:10.1016/j.mce.2010.04.005.
   PubMed Web of Science ®Google Scholar
• Bruewer M, Hopkins AM, Hobert ME, Nusrat A, Madara JL. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. Am J Physiol Cell Physiol. 2004;287(2):C327–35. doi:10.1152/ajpcell.00087.2004.
   PubMed Web of Science ®Google Scholar
• Citi S, Guerrera D, Spadaro D, Shah J. Epithelial junctions and Rho family GTPases: the zonular signalosome. Small GTPases. 2014;5(4):1–15. doi:10.4161/21541248.2014.973760.
   PubMedGoogle Scholar
• Krug SM, Schulzke JD, Fromm M. Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol. 2014;36:166–176. doi:10.1016/j.semcdb.2014.09.002.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta. 2008;1778(3):729–756. doi:10.1016/j.bbamem.2007.08.018.
   PubMed Web of Science ®Google Scholar
• Dorfel MJ, Huber O. Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol. 2012;2012:807356. doi:10.1155/2012/807356.
   PubMedGoogle Scholar
• Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 2004;286(6):C1213–28. doi:10.1152/ajpcell.00558.2003.
   PubMed Web of Science ®Google Scholar
• Turner JR, Buschmann MM, Romero-Calvo I, Sailer A, Shen L. The role of molecular remodeling in differential regulation of tight junction permeability. Semin Cell Dev Biol. 2014;36:204–212. doi:10.1016/j.semcdb.2014.09.022.
   PubMed Web of Science ®Google Scholar
• Hidalgo IJ, Raut TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 1989;96(3):736–749. doi:10.1038/nrgastro.2016.142.
   PubMed Web of Science ®Google Scholar
• Loren V, Cabré E, Ojanguren I, Domènech E, Pedrosa E, García-Jaraquemada A, Mañosa M, Manyé J, Schneider-Stock R. Interleukin-10 enhances the intestinal epithelial barrier in the presence of corticosteroids through p38 MAPK activity in Caco-2 monolayers: a possible mechanism for steroid responsiveness in ulcerative colitis. PLoS One. 2015;10(6):e0130921. doi:10.1371/journal.pone.0130921.
   PubMed Web of Science ®Google Scholar
• Inamochi Y, Mochizuki K, Goda T. Histone code of genes induced by co-treatment with a glucocorticoid hormone agonist and a p44/42 MAPK inhibitor in human small intestinal Caco-2 cells. Biochim Biophys Acta. 2014;1840(1):693–700. doi:10.1016/j.bbagen.2013.10.026.
   PubMed Web of Science ®Google Scholar
• Raddatz D, Toth S, Schwörer H, Ramadori G. Glucocorticoid receptor signaling in the intestinal epithelial cell lines IEC-6 and Caco-2: evidence of inhibition by interleukin-1beta. Int J Colorectal Dis. 2001;16:377–383.
   PubMed Web of Science ®Google Scholar
• Mochizuki K, Takabe S, Goda T. Changes on histone H3 modifications on the GLUT5 gene and its expression in Caco-2 cells co-treated with a p44/42 MAPK inhibitor and glucocorticoid hormone. Biochem Biophys Res Commun. 2008;371(2):324–327. doi:10.1016/j.bbrc.2008.04.075.
   PubMed Web of Science ®Google Scholar
• Zheng G, Victor Fon G, Meixner W, Creekmore A, Zong Y, K. Dame M, Colacino J, Dedhia PH, Hong S, Wiley JW. Chronic stress and intestinal barrier dysfunction: glucocorticoid receptor and transcription repressor HES1 regulate tight junction protein Claudin-1 promoter. Sci Rep. 2017;7(1):4502. doi:10.1038/s41598-017-04755-w.
   PubMedGoogle Scholar
• Fischer A, Gluth M, Weege F, Pape U-F, Wiedenmann B, Baumgart DC, Theuring F. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1. Am J Physiol Gastrointest Liver Physiol. 2014;306(3):G218–28. doi:10.1152/ajpgi.00095.2013.
   PubMed Web of Science ®Google Scholar
• Sääf AM, Halbleib JM, Chen X, Yuen ST, Leung SY, Nelson WJ, Brown PO. Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancer. Mol Biol Cell. 2007;18(11):4245–4260. doi:10.1091/mbc.e07-04-0309.
   PubMed Web of Science ®Google Scholar
• Halbleib JM, Sääf AM, Brown PO, Nelson WJ. Transcriptional modulation of genes encoding structural characteristics of differentiating enterocytes during development of a polarized epithelium in vitro. Mol Biol Cell. 2007;18(11):4261–4278. doi:10.1091/mbc.e07-04-0308.
   PubMed Web of Science ®Google Scholar
• Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26(3):317–325. doi:10.1038/nbt1385.
   PubMed Web of Science ®Google Scholar
• Natoli M, Leoni BD, D’Agnano I, Zucco F, Felsani A. Good Caco-2 cell culture practices. Toxicol In Vitro. 2012;26(8):1243–1246. doi:10.1016/j.tiv.2012.03.009.
   PubMed Web of Science ®Google Scholar
• Blume LF, Denker M, Gieseler F, Kunze T. Temperature corrected transepithelial electrical resistance (TEER) measurement to quantify rapid changes in paracellular permeability. Pharmazie. 2010;65:19–24.
   PubMed Web of Science ®Google Scholar
• Robinson JM, Henderson WA. Modelling the structure of a ceRNA-theoretical, bipartite microRNA-mRNA interaction network regulating intestinal epithelial cellular pathways using R programming. BMC Res Notes. 2018;11(1):19. doi:10.1186/s13104-018-3126-y.
   PubMedGoogle Scholar
• Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30. doi:10.1093/nar/28.1.27.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. doi:10.1126/science.1260419.
   PubMed Web of Science ®Google Scholar
• Abey SK, Yuana Y, Joseph PV, Kenea ND, Fourie NH, Sherwin LB, Gonye GE, Smyser PA, Stempinski ES, Boulineaux CM, et al. Lysozyme association with circulating RNA, extracellular vesicles, and chronic stress. BBA Clin. 2017;7:23–35. doi:10.1016/j.bbacli.2016.12.003.
   PubMed Web of Science ®Google Scholar
• Bekku S, Mochizuki H, Takayama E, Shinomiya N, Fukamachi H, Ichinose M, Tadakuma T, Yamamoto T. Carbonic anhydrase I and II as a differentiation marker of human and rat colonic enterocytes. Res Exp Med (Berl). 1998;198:175–185.
   PubMedGoogle Scholar
• Marcato P, Dean CA, Giacomantonio CA, Lee PWK. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle. 2011;10(9):1378–1384. doi:10.4161/cc.10.9.15486.
   PubMed Web of Science ®Google Scholar
• Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034. doi:10.1186/gb-2002-3-7-research0034.
   PubMed Web of Science ®Google Scholar
• Perkins JR, Dawes JM, McMahon SB, Bennett DL, Orengo C, Kohl M. ReadqPCR and NormqPCR: R packages for the reading, quality checking and normalisation of RT-qPCR quantification cycle (Cq) data. BMC Genomics. 2012;13:296. doi:10.1186/1471-2164-13-296.
   PubMed Web of Science ®Google Scholar
• Fabregat A, Jupe S, Matthews L, Sidiropoulos K, Gillespie M, Garapati P, Haw R, Jassal B, Korninger F, May B, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2018;46(D1):D649–D655. doi:10.1093/nar/gkx1132.
   PubMed Web of Science ®Google Scholar
• Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29(14):1830–1831. doi:10.1093/bioinformatics/btt285.
   PubMed Web of Science ®Google Scholar
• Robinson JM, Abey SA, Kenea N, Henderson WA. A 14-day Dexamethasone timecourse exposure in Caco-2 monolayers results in differential expression of tight-junction and cytoskeleton regulatory pathway genes. bioRxiv. 2018. doi:https://doi.org/10.1101/35552.
   Google Scholar
• Iden S, Collard JG. Crosstalk between small GTPases and polarity proteins in cell polarization. Nat Rev Mol Cell Biol. 2008;9(11):846–859. doi:10.1038/nrm2521.
   PubMed Web of Science ®Google Scholar
• Di Ruscio M, Vernia F, Ciccone A, Frieri G, Latella G. Surrogate fecal biomarkers in inflammatory bowel disease: rivals or complementary tools of fecal calprotectin? Inflamm Bowel Dis. 2017;24(1):78–92. doi:10.1093/ibd/izx011.
   PubMed Web of Science ®Google Scholar
• Wei P, Inamdar N, Vedeckis WV. Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter. Mol Endocrinol. 1998;12(9):1322–1333. doi:10.1210/mend.12.9.0158.
   PubMedGoogle Scholar
• Boudreau F, Caulfield JB, Norton P, Chantler PD, Deziel MR, Slayter HS, Margossian SS. Negative regulation of glucocorticoid-dependent induction of c-fos by ras in intestinal epithelial cells. Mol Cell Biochem. 1999;195(1–2):99–111.
   Web of Science ®Google Scholar
• Tiwari G, Tiwari R, Rai AK. Cyclodextrins in delivery systems: Applications. J Pharm Bioallied Sci. 2010;2(2):72–79. doi:10.4103/0975-7406.67003.
   PubMedGoogle Scholar
• Muankaew C, Loftsson T. Cyclodextrin-based formulations: a non-invasive platform for targeted drug delivery. Basic Clin Pharmacol Toxicol. 2018;122(1):46–55. doi:10.1111/bcpt.12917.
   PubMed Web of Science ®Google Scholar
• Beig A, Agbaria R, Dahan A, Tajmir-Riahi H-A. Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations. PLoS One. 2013;8(7):e68237. doi:10.1371/journal.pone.0068237.
   PubMed Web of Science ®Google Scholar
• Fine-Shamir N, Beig A, Zur M, Lindley D, Miller JM, Dahan A. Toward successful cyclodextrin based solubility-enabling formulations for oral delivery of lipophilic drugs: solubility-permeability trade-off, biorelevant dissolution, and the unstirred water layer. Mol Pharm. 2017;14(6):2138–2146. doi:10.1021/acs.molpharmaceut.7b00275.
   PubMed Web of Science ®Google Scholar
• Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov. 2004;3(12):1023–1035. doi:10.1038/nrd1576.
   PubMed Web of Science ®Google Scholar
• Celik S, Logsdon BA, Battle S, Drescher CW, Rendi M, Hawkins RD, Lee S-I. Extracting a low-dimensional description of multiple gene expression datasets reveals a potential driver for tumor-associated stroma in ovarian cancer. Genome Med. 2016;8(1):66. doi:10.1186/s13073-016-0319-7.
   PubMedGoogle Scholar
• Tan HY, Trier S, Rahbek UL, Dufva M, Kutter JP, Andresen TL, Deli MA. A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies. PLoS One. 2018;13(5):e0197101. doi:10.1371/journal.pone.0197101.
   PubMed Web of Science ®Google Scholar
• In JG, Foulke-Abel J, Estes MK, Zachos NC, Kovbasnjuk O, Donowitz M, Hidalgo IJ, Raub TJ, Borchardt RT. Human mini-guts: new insights into intestinal physiology and host-pathogen interactions. Nat Rev Gastroenterol Hepatol. 2016;13(11):633–642. doi:10.1038/nrgastro.2016.142.
   PubMed Web of Science ®Google Scholar